The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Viral Detection Market Research Report 2024

Global Viral Detection Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1885407

No of Pages : 83

Synopsis
The global Viral Detection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Viral Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Viral Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Viral Detection in Blood & Blood Products is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Viral Detection include Avance Biosciences Inc (US), BSL BIOSERVICE (Germany), Clean Cells (France), Charles River Laboratories International, Inc (US), Lonza Group (Switzerland), Merck KGaA (Germany), Sigma-Aldrich Corporation (US), SGS S.A. (Switzerland) and Texcell, Inc. (France), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Viral Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Detection.
Report Scope
The Viral Detection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Detection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Avance Biosciences Inc (US)
BSL BIOSERVICE (Germany)
Clean Cells (France)
Charles River Laboratories International, Inc (US)
Lonza Group (Switzerland)
Merck KGaA (Germany)
Sigma-Aldrich Corporation (US)
SGS S.A. (Switzerland)
Texcell, Inc. (France)
WuXi PharmaTech (Cayman) Inc. (China)
Segment by Type
Plaque Assays
PCR
ELISA
Others
Segment by Application
Blood & Blood Products
Cellular & Gene Therapy Products
Stem Cell Products
Tissue & Tissue Products
Vaccines and Therapeutics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Detection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Plaque Assays
1.2.3 PCR
1.2.4 ELISA
1.2.5 Others
1.3 Market by Application
1.3.1 Global Viral Detection Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Blood & Blood Products
1.3.3 Cellular & Gene Therapy Products
1.3.4 Stem Cell Products
1.3.5 Tissue & Tissue Products
1.3.6 Vaccines and Therapeutics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Detection Market Perspective (2019-2030)
2.2 Viral Detection Growth Trends by Region
2.2.1 Global Viral Detection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Detection Historic Market Size by Region (2019-2024)
2.2.3 Viral Detection Forecasted Market Size by Region (2025-2030)
2.3 Viral Detection Market Dynamics
2.3.1 Viral Detection Industry Trends
2.3.2 Viral Detection Market Drivers
2.3.3 Viral Detection Market Challenges
2.3.4 Viral Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Detection Players by Revenue
3.1.1 Global Top Viral Detection Players by Revenue (2019-2024)
3.1.2 Global Viral Detection Revenue Market Share by Players (2019-2024)
3.2 Global Viral Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Detection Revenue
3.4 Global Viral Detection Market Concentration Ratio
3.4.1 Global Viral Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Detection Revenue in 2023
3.5 Viral Detection Key Players Head office and Area Served
3.6 Key Players Viral Detection Product Solution and Service
3.7 Date of Enter into Viral Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Detection Breakdown Data by Type
4.1 Global Viral Detection Historic Market Size by Type (2019-2024)
4.2 Global Viral Detection Forecasted Market Size by Type (2025-2030)
5 Viral Detection Breakdown Data by Application
5.1 Global Viral Detection Historic Market Size by Application (2019-2024)
5.2 Global Viral Detection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Detection Market Size (2019-2030)
6.2 North America Viral Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Detection Market Size by Country (2019-2024)
6.4 North America Viral Detection Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Detection Market Size (2019-2030)
7.2 Europe Viral Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Detection Market Size by Country (2019-2024)
7.4 Europe Viral Detection Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Detection Market Size (2019-2030)
8.2 Asia-Pacific Viral Detection Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Detection Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Detection Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Detection Market Size (2019-2030)
9.2 Latin America Viral Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Detection Market Size by Country (2019-2024)
9.4 Latin America Viral Detection Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Detection Market Size (2019-2030)
10.2 Middle East & Africa Viral Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Detection Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Detection Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Avance Biosciences Inc (US)
11.1.1 Avance Biosciences Inc (US) Company Detail
11.1.2 Avance Biosciences Inc (US) Business Overview
11.1.3 Avance Biosciences Inc (US) Viral Detection Introduction
11.1.4 Avance Biosciences Inc (US) Revenue in Viral Detection Business (2019-2024)
11.1.5 Avance Biosciences Inc (US) Recent Development
11.2 BSL BIOSERVICE (Germany)
11.2.1 BSL BIOSERVICE (Germany) Company Detail
11.2.2 BSL BIOSERVICE (Germany) Business Overview
11.2.3 BSL BIOSERVICE (Germany) Viral Detection Introduction
11.2.4 BSL BIOSERVICE (Germany) Revenue in Viral Detection Business (2019-2024)
11.2.5 BSL BIOSERVICE (Germany) Recent Development
11.3 Clean Cells (France)
11.3.1 Clean Cells (France) Company Detail
11.3.2 Clean Cells (France) Business Overview
11.3.3 Clean Cells (France) Viral Detection Introduction
11.3.4 Clean Cells (France) Revenue in Viral Detection Business (2019-2024)
11.3.5 Clean Cells (France) Recent Development
11.4 Charles River Laboratories International, Inc (US)
11.4.1 Charles River Laboratories International, Inc (US) Company Detail
11.4.2 Charles River Laboratories International, Inc (US) Business Overview
11.4.3 Charles River Laboratories International, Inc (US) Viral Detection Introduction
11.4.4 Charles River Laboratories International, Inc (US) Revenue in Viral Detection Business (2019-2024)
11.4.5 Charles River Laboratories International, Inc (US) Recent Development
11.5 Lonza Group (Switzerland)
11.5.1 Lonza Group (Switzerland) Company Detail
11.5.2 Lonza Group (Switzerland) Business Overview
11.5.3 Lonza Group (Switzerland) Viral Detection Introduction
11.5.4 Lonza Group (Switzerland) Revenue in Viral Detection Business (2019-2024)
11.5.5 Lonza Group (Switzerland) Recent Development
11.6 Merck KGaA (Germany)
11.6.1 Merck KGaA (Germany) Company Detail
11.6.2 Merck KGaA (Germany) Business Overview
11.6.3 Merck KGaA (Germany) Viral Detection Introduction
11.6.4 Merck KGaA (Germany) Revenue in Viral Detection Business (2019-2024)
11.6.5 Merck KGaA (Germany) Recent Development
11.7 Sigma-Aldrich Corporation (US)
11.7.1 Sigma-Aldrich Corporation (US) Company Detail
11.7.2 Sigma-Aldrich Corporation (US) Business Overview
11.7.3 Sigma-Aldrich Corporation (US) Viral Detection Introduction
11.7.4 Sigma-Aldrich Corporation (US) Revenue in Viral Detection Business (2019-2024)
11.7.5 Sigma-Aldrich Corporation (US) Recent Development
11.8 SGS S.A. (Switzerland)
11.8.1 SGS S.A. (Switzerland) Company Detail
11.8.2 SGS S.A. (Switzerland) Business Overview
11.8.3 SGS S.A. (Switzerland) Viral Detection Introduction
11.8.4 SGS S.A. (Switzerland) Revenue in Viral Detection Business (2019-2024)
11.8.5 SGS S.A. (Switzerland) Recent Development
11.9 Texcell, Inc. (France)
11.9.1 Texcell, Inc. (France) Company Detail
11.9.2 Texcell, Inc. (France) Business Overview
11.9.3 Texcell, Inc. (France) Viral Detection Introduction
11.9.4 Texcell, Inc. (France) Revenue in Viral Detection Business (2019-2024)
11.9.5 Texcell, Inc. (France) Recent Development
11.10 WuXi PharmaTech (Cayman) Inc. (China)
11.10.1 WuXi PharmaTech (Cayman) Inc. (China) Company Detail
11.10.2 WuXi PharmaTech (Cayman) Inc. (China) Business Overview
11.10.3 WuXi PharmaTech (Cayman) Inc. (China) Viral Detection Introduction
11.10.4 WuXi PharmaTech (Cayman) Inc. (China) Revenue in Viral Detection Business (2019-2024)
11.10.5 WuXi PharmaTech (Cayman) Inc. (China) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’